Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Aug 13Aug 13
Quote
Day Range
$0.91 – $0.98
52-Week Range
$0.75 – $2.29
Volume
$153.7K
Market Cap
$14.49M
50-Day Avg
$0.94
200-Day Avg
$1.16
Prev Close
$0.93
Open
$0.94
Valuation & Ratios
P/E Ratio
-1.02
EPS
$-1.23
P/B Ratio
9.31
P/S Ratio
0.00
Debt/Equity
0.59
Current Ratio
1.12
Dividend Yield
+0.0%
Gross Margin
+0.0%
Returns & Efficiency
Return on Equity
-919.3%
Return on Assets
-241.1%
FCF Yield
-89.3%
EV/EBITDA
-0.82
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-8.23M | $-1.23 |
| 2024 | $58.0K | $-7.95M | $-2.90 |
| 2023 | $477.0K | $-11.57M | $-8.19 |
| 2022 | $1.35M | $-11.91M | $-10.05 |
| 2021 | $1.01M | $-12.62M | $-11.19 |
Social Signal Score
70
5d
70
1 mentions
—
30d
70
1 mentions
—
60d
70
1 mentions
—
90d
70
1 mentions
—
news: 1
Earnings
Wed, Nov 11(in 3 months)
Consensus estimate $-0.15 per share
4of 7 quarters beat consensus
Typical surprise +4.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$-0.13 vs $-0.18beat
- Fri, May 15$-0.21 vs $-0.17miss
- Tue, Mar 24$-0.06 vs $-0.20beat
- Wed, Nov 12$-0.24 vs $-0.25beat
- Mon, Aug 11$-0.40 vs $-0.25miss
- Wed, May 14$-0.59 vs $-0.39miss
Estimates and results for BCDA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
BCDAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsseekingalpha.com·2d ago·Positive
BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript
View source ↗